Monday morning on the Tennessee Star Report, host Michael Patrick Leahy welcomed the original all-star panelist Crom Carmichael to the studio to discuss Big Pharma and the illusion of a free market.
Read the full story
A Kodak moment for the books: the former film giant flipped to pharma in a move aimed to rejuvenate the company after nearly two decades of hardship. Several reports state that Kodak branched out to offset the large-scale loss of its film business – punctuated by a bankruptcy in 2012 after the concept of the digital camera that it invented rendered many of its product offerings obsolete.
Initial talks of Kodak’s new active pharmaceutical ingredients (APIs) division, branded “Kodak Pharmaceuticals,” began as early as a few months ago according to Kodak CEO Jim Continenza. He says the move shouldn’t be all that surprising.
Read the full story
In a special interview, Tuesday morning on the Tennessee Star Report with Michael Patrick Leahy – broadcast on Nashville’s Talk Radio 98.3 and 1510 WLAC weekdays from 5:00 a.m. to 8:00 a.m. – host Michael Patrick Leahy welcomed U.S. Republican Sen. Marsha Blackburn of Tennessee to the newsmakers line.
Read the full story
by Molly Prince Democratic Sen. Elizabeth Warren introduced legislation on Tuesday that would establish a government-run pharmaceutical manufacturer to effectively compete with the private market. The Affordable Drug Manufacturing Act seeks to address the increasing prices of prescription drugs by injecting competition into the marketplace, consequently lowering the cost of mass-produced generic drugs. The bill would create the Office of Drug Manufacturing, which would be housed within the Department of Health and Human Services (HHS). Warren said that adding the agency would increase competition. “In market after market, competition is dying as a handful of giant companies spend millions to rig the rules, insulate themselves from accountability, and line their pockets at the expense of American families,” Warren said in a statement. “The solution here is not to replace markets, but to fix them.” According to the bill, the Office of Drug Manufacturing would be tasked with producing drugs in cases where the market has been deemed to have failed. For example, in addition to requiring the agency to produce generic insulin within one year of authorization, it will be permitted to manufacture any prescription drug that the government has licensed. Moreover, the office can manufacture generic drugs if: No company…
Read the full story